Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China
· Delayed Price · Currency is CNY 22.36
-0.51 (-2.23%)
May 21, 2025, 2:45 PM CST
SHA:600645 Revenue
Vcanbio Cell & Gene Engineering Corp., had revenue of 350.79M CNY in the quarter ending March 31, 2025, a decrease of -11.86%. This brings the company's revenue in the last twelve months to 1.54B, down -4.46% year-over-year. In the year 2024, Vcanbio Cell & Gene Engineering Corp., had annual revenue of 1.59B, down -0.27%.
Revenue (ttm)
1.54B
Revenue Growth
-4.46%
P/S Ratio
6.78
Revenue / Employee
763.77K
Employees
2,209
Market Cap
10.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.59B | -4.30M | -0.27% |
| Dec 31, 2023 | 1.59B | 34.84M | 2.24% |
| Dec 31, 2022 | 1.55B | 19.56M | 1.27% |
| Dec 31, 2021 | 1.54B | 216.43M | 16.41% |
| Dec 31, 2020 | 1.32B | -67.88M | -4.90% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |